Navigation Links
Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Date:11/14/2007

multi-center randomized trial comparing the ClosureFAST treatment to endovenous laser. Patients undergoing laser treatment were 33% more likely to experience pain and 50% more likely to require postoperative pain medication than patients who received the ClosureFast treatment.

"The ClosureFAST device is clearly emerging as the preferred treatment for venous reflux, in part because of reduced patient discomfort after treatment," said Dr. Almeida. "While procedure time and short-term efficacy are comparable between ClosureFAST and laser, we're definitely seeing a superior patient recovery profile with ClosureFAST."

"We are pleased to see the positive interim study results on our ClosureFAST catheter, especially the favorable patient recovery profile compared to laser treatment and the better-than-anticipated one-year efficacy rate," said Brian E. Farley, President and CEO of VNUS. "We believe the final results will support our belief that ClosureFAST is the best choice for the treatment of venous reflux disease for the millions of varicose vein sufferers around the world."

ABOUT VEITH SYMPOSIUM

Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The five-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. VEITHsymposium is sponsored by The Cleveland Clinic, Cleveland, OH.

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (Nasdaq:

SOURCE VNUS Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
6. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LOS ANGELES , Aug. 20, 2014   Easy Breathe ... today announced that its " Easy Blog " - has received ... the year.   "We are thrilled that so many ... Nick Weiss , CEO of Easy Breathe. "We,re committed to making ... use Easy Blog to stay informed about sleep apnea news ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... SAN MARCOS, Texas , Aug. 20, 2014 ... purchase of five diverse sets of patent families ... and major innovation driver for Bayer AG of ... The patents acquired provide broad intellectual property ... achieved in economical high-volume quantum dot (QD) manufacturing. ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
... Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present ... April 25, 2012. The conference is being held at ... The IN3 Medical Device 360 Conference is hosted by ... networking meeting. The goal of the meeting is ,partnering ...
... April 25, 2012 Aethlon Medical, Inc. ... its Chairman and CEO, Jim Joyce. (Photo: ... originally formed to advance a medical device technology that ... the time, our strategy to treat infectious disease was ...
Cached Medicine Technology:Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London 2Aethlon Medical Note: Marc Robins Joins the Aethlon Team 2
(Date:8/20/2014)... 20, 2014 Botanica Day ... facial. Utilizing the new and popular stem cell ... fine lines and wrinkles and naturally repairs the ... highlighting the new service by offering clients a ... stem cell facial. , Pevonia® continues to be ...
(Date:8/20/2014)... -- Leaving the car at home and getting to work ... health, a new study indicates. Researchers looked at thousands ... percent of men and 72 percent of women drove to ... used public transit, and 14 percent of men and 17 ... to work weighed more and had higher levels of body ...
(Date:8/20/2014)... Chemically extracted acellular allogeneic nerve, from which ... have been removed, reduced postoperative immune rejection. ... neural substrates and base materials, such as ... can provide a good scaffold in the ... allogeneic nerve, similar to autologous nerve transplantation, ...
(Date:8/20/2014)... 20, 2014 Fresh from the cradle of ... sprung from the starting blocks. , Urbini, a new collection ... the Urbini Avi jogger to its lineup. , ... with a look inspired by the latest racing styles and ... , This versatile jogger offers a swift, smooth ride on ...
(Date:8/20/2014)... August 20, 2014 The National ... five-year, $1.24 million Science Education Partnership Award (SEPA) ... support NAHN’s collaborative project with the Hispanic Communications ... Careers. , This collaborative NIH R25 program has ... and linguistic diversity among health professionals by recruiting ...
Breaking Medicine News(10 mins):Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Want to Stay Slim? Leave the Car at Home 2Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3
... Irvine scientists will receive grants totaling $9.35 million to ... disease and traumatic brain injury. The grants from ... Oct. 21, to Dr. Henry Klassen, Leslie M. Thompson, ... the Sue and Bill Gross Stem Cell Research Center ...
... interdisciplinary approach to drug abuse and addiction research, The ... has been renewed as a "Center of Excellence" by ... National Institutes of Health. The designation comes with ... to further studies led by researchers and clinicians in ...
... University of California, San Diego School of Medicine indicates that ... plans that include parents and child, while at the same ... , The results were published today in the advanced online ... Boutelle, PhD, associate professor of pediatrics and psychiatry at UC ...
... (HealthDay News) -- A new study suggests that in women ... tissue in addition to a cancerous breast tumor is enough ... about how much of a "free margin" around a tumor ... the November issue of IJCP, the International Journal of ...
... A new research study conducted by Boston University ... significantly improve biennial mammography screening rates among inner city ... Journal of General Internal Medicine , indicate the importance ... patient populations. Breast cancer is the second ...
... , THURSDAY, Oct. 21 (HealthDay News) -- Over the ... in the United States will be 10 times greater ... that could affect cancer patients, access to treatment, according ... the number of patients requiring radiation therapy will increase ...
Cached Medicine News:Health News:UCI stem cell researchers to receive $9.35 million in state funding 2Health News:UCI stem cell researchers to receive $9.35 million in state funding 3Health News:UTHealth receives $11 million NIDA grant 2Health News:Parent-only treatment may be equally effective for children who are obese 2Health News:New Finding Suggests Safe Surgical Margins When Removing Breast Cancers 2Health News:BUSM study shows patient navigations improve mammography rates in minority women 2Health News:Demand for Radiation Therapy Predicted to Exceed Supply 2
The GII titanium anchor with nitinol arcs is used for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor used by...
... loupe provides greater definition than a ... of view. The Hi-Res five element ... in a lightweight system., ,Order frame ... are supplied in a soft carrying ...
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
... The Chan Wristrest has become an important ... adjustable horseshoe bar encircles the patient's head and ... horseshoe bar facilitates easy draping especially when fluids ... out of the way for easy patient transfer ...
Medicine Products: